Peripheral Blood DNA Methylation Changes Precede Lymphoma Diagnosis in Primary Sjögren's Disease
Arthritis & Rheumatology · 20.07.2026
DOI: 10.1002/art.70271 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 20.07.2026. Verfasst von Hanna Lidberg und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Rheumatology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stiftelsen Konung Gustaf V:s 80-årsfond, Reumatikerförbundet.
Abstract (Originalsprache)
Objective
Primary Sjögren's disease (SjD) is a systemic autoimmune disease associated with an increased risk of lymphoma. The molecular mechanisms underlying lymphomagenesis remain poorly understood, and sensitive biomarkers for early identification of patients at high risk of developing lymphoma are lacking. This study investigated whether DNA methylation patterns in blood are associated with subsequent development of lymphoma in patients with SjD.
Methods
Peripheral blood DNA samples collected from patients with SjD between 1998 and 2013 were analyzed using the Illumina HumanMethylation450K BeadChip. There were 6 patients who developed lymphoma at one or more years after blood sampling, henceforth referred to as “patients with SjD pre‐lymphoma”; 84 patients with SjD did not develop lymphoma, and they are henceforth referred to as “patients with only SjD.” Epigenome‐wide association analyses were adjusted for age, sex, and estimated blood cell–type proportions. Differentially methylated CpG positions (DMPs) were defined by Bonferroni‐corrected P ≤ 1.3 × 10 −7 and |Δβ| > 0.05. Functional enrichment was assessed using Enrichr and Interferome version 2.01.
Results
A total of 473 autosomal and 1 X‐chromosomal DMPs distinguished patients with SjD pre‐lymphoma from patients with only SjD, with 87% of DMPs being hypomethylated in patients with SjDpl. The most significant DMP mapped to Thymidine kinase 1 ( TK1 ; P = 7.6 × 10 −15 , Δβ = −0.16), followed by FCER1G and MDH2 . Functional annotation revealed enrichment for immune activation, leukocyte signaling, and vesicle‐mediated secretion pathways. Patients with SjD pre‐lymphoma also exhibited reduced natural killer cells and increased monocyte proportions, consistent with an altered immune milieu.
Conclusion
Distinct DNA methylation changes precede lymphoma in SjD, affecting genes involved in immune regulation, cytotoxic function, and proliferation. Although exploratory and requiring replication, these findings provide a framework for integrating epigenetic, clinical, and serologic markers to inform early risk stratification in patients with SjD.
Autor:innen und Institutionen
- Department of Medical Sciences, Rheumatology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
ORCID-Profile: Cecilia Fugmann, Juliana Imgenberg-Kreuz
Förderung
- Stiftelsen Konung Gustaf V:s 80-årsfond
- Reumatikerförbundet
Zitieren
APA
Lidberg, H., Fugmann, C., & Imgenberg-Kreuz, J. (2026). Peripheral Blood DNA Methylation Changes Precede Lymphoma Diagnosis in Primary Sjögren's Disease. Arthritis & Rheumatology. https://doi.org/10.1002/art.70271
Vancouver
Lidberg H, Fugmann C, Imgenberg-Kreuz J. Peripheral Blood DNA Methylation Changes Precede Lymphoma Diagnosis in Primary Sjögren's Disease. Arthritis & Rheumatology. 2026. doi:10.1002/art.70271
BibTeX
@article{Lidberg2026,
author = {Lidberg, Hanna and Fugmann, Cecilia and Imgenberg-Kreuz, Juliana},
title = {Peripheral Blood DNA Methylation Changes Precede Lymphoma Diagnosis in Primary Sjögren's Disease},
journal = {Arthritis & Rheumatology},
year = {2026},
doi = {10.1002/art.70271}
}
EUVIMED